Search Ontology:
ChEBI
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
- Term ID
- CHEBI:61576
- Synonyms
-
- (Gal)2 (GalNAc)1 (Glc)1 (LFuc)1 (Cer)1
- a ganglioside Fuc-GA1 (d18:1(4E))
- alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-beta-D-N-acetylgalactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
- Definition
- A glycopentaosylceramide having alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc as the glycopentaosyl component.
- References
-
- KEGG:G00476
- PMID:8905401
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype where environments contain alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype modified by environments containing alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype affecting alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Human Disease Model